Visual Portfolio, Posts & Image Gallery for WordPress

COVID-19 Study’s Early Insights Shed Light on New Trends 

December 15, 2020
Since the launch of our COVID-19 Study in March 2020, LunaDNA members have submitted over 340,000 responses to gather physical and mental wellness information directly from individuals during this global pandemic. Early insights we previously released in July revealed that one in six participants had taken a COVID-19 test and…

LunaDNA Reveals Early Insights from the COVID-19 Study

August 5, 2020
In March 2020, LunaDNA, in partnership with Genetic Alliance, opened a COVID-19 study to gather physical and mental wellness information directly from individuals during the global pandemic. As of today, individuals from across the country and beyond have submitted over 187,000 survey responses revealing some remarkable early insights that have been presented to noteworthy science organizations. The study is still open and all are welcome and encouraged to share their…

KCNT1 Epilepsy Foundation, LunaPBC, and Genetic Alliance to Launch Patient-Led Discovery Program

May 26, 2020
Program incorporates patient-driven study to inform research and drug development for KCNT1-related epilepsy. SAN DIEGO and WASHINGTON, May 26, 2020 /PRNewswire/ — The KCNT1 Epilepsy Foundation, LunaPBC, and Genetic Alliance today announced a program to assemble a patient-led drug discovery community to study disease etiology and develop therapeutic interventions for patients with KCNT1-related epilepsy. The program is being launched in…